Abstract:Many Ser/Thr protein kinases, to be fully activated, are obligated to introduce a phospho-Ser/Thr in their activation loop. Presently, the similarity of activation loop between two crystal complexes, i.e. glycogen synthase kinase 3 beta (GSK3 beta)-AMPNP and GSK3 beta-sulfate ion complex, indicates that the activation segment of GSK3 beta is preformed requiring neither a phosphorylation event nor conformational changes. GSK3 beta, when participated in glycogen synthesis and Wnt signaling pathways, possesses a unique feature with the preference of such substrate with a priming phosphate. Experimental mutagenesis proved that the residue arginine at amino acid 96 mutations to lysine (R96K) or alanine (R96A) selectively abolish activity on the substrates involved in glycogen synthesis signaling pathway. Based on two solved crystal structures, wild type (WT) and two mutants (R96K and R96A) GSK3 beta-ATP-phospho-Serine (pSer) complexes were modeled. Molecular dynamics simulations and energy analysis were employed to investigate the effect of pSer involvement on the GSK3 beta structure in WT, and the mechanisms of GSK3 beta deactivation due to R96K and R96A mutations. The results indicate that the introduction of pSer to WT GSK3 beta generates a slight lobe closure on GSK3 beta without any remarkable changes, which may illuminate the experimental conclusion, whereas the conformations of GSK3 beta and ATP undergo significant changes in two mutants. As to GSK3 beta, the affected positions distribute over activation loop, alpha-helix, and glycine-rich loop. Based on coupling among the mentioned positions, the allosteric mechanisms for distorted ATP were proposed. Energy decomposition on the residues of activation loop identified the important residues Arg96 and Arg180 in anchoring the phosphate group.

Crystal Structure of E339K Mutated Human Glucokinase Reveals Changes in the ATP Binding Site

Insight into the Biochemical Characteristics of a Novel Glucokinase Gene Mutation.

Mechanism of Kinase Inactivation and Nonbinding of FRATide to GSK3β Due to K85M Mutation: Molecular Dynamics Simulation and Normal Mode Analysis.

The Functional Analysis of Glucokinase Gene E339K Mutation

Mutation of the Conserved G66 Residue in GS Region Decreased Structural Stability and Activity of Arginine Kinase

Effect of Double Mutations K214/A–E215/Q of FRATide on GSK3β: Insights from Molecular Dynamics Simulation and Normal Mode Analysis

Structural basis for the complete loss of GSK3beta catalytic activity due to R96 mutation investigated by molecular dynamics study.

Effect of Mutation K85R on GSK-3beta: Molecular Dynamics Simulation.

Disrupting of E79 and K138 Interaction is Responsible for Human Muscle Creatine Kinase Deficiency Diseases

Structural Basis for Allosteric Regulation of the Monomeric Allosteric Enzyme Human Glucokinase

Roles of Amino Acid Residues H66 and D326 in the Creatine Kinase Activity and Structural Stability

The Crystal Structure of Human UDP-glucose Pyrophosphorylase Reveals a Latch Effect That Influences Enzymatic Activity.

Phenotypic characterization of congenital hyperinsulinism due to novel activating glucokinase mutations

Acetylation of glucokinase regulatory protein decreases glucose metabolism by suppressing glucokinase activity

Single Nucleotide Polymorphisms in KATP Channels

Structural basis for ADP-dependent glucokinase inhibition by 8-bromo–substituted adenosine nucleotide

T273 Plays an Important Role in the Activity and Structural Stability of Arginine Kinase.

Susceptibility of Glucokinase-MODY Mutants to Inactivation by Oxidative Stress in Pancreatic β-Cells

Crystal Structure of the Human Glucose Transporter GLUT1

Crystal structure of a catalytic site mutant of beta-amylase from Bacillus cereus var. mycoides cocrystallized with maltopentaose

Characterization of a naturally occurring mutation V368M in the human glucagon receptor and its association with metabolic disorders